Vimarsana
Biggest News Aggregation in the World

M Squared Associates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from M Squared Associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In M Squared Associates Today - Breaking & Trending Today

ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services - Vimarsana News

ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services

Chicago, IL (PRWEB) August 23, 2022 -- ProPharma Group’s acquisition of OSR is an advancement in its dynamic growth strategy, focused on combining

Source: prweb.com
Odyssey-backed PPG buys M Squared Associates - Vimarsana News

Odyssey-backed PPG buys M Squared Associates

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry.

Source: pehub.com
ProPharma Group Announces the Acquisition of M Squared Associates - Vimarsana News

ProPharma Group Announces the Acquisition of M Squared Associates

Overland Park (PRWEB) March 18, 2022 -- ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared

Source: prweb.com
GBT Tokenize Engaged M Squared Associates to Support FDA 510(k) Submission for qTerm - Vimarsana News

GBT Tokenize Engaged M Squared Associates to Support FDA 510(k) Submission for qTerm

Press release content from Globe Newswire. The AP news staff was not involved in its creation. GBT Tokenize Engaged M Squared Associates to Support FDA 510(k) Submission for qTerm GBT Technologies Inc.January 28, 2021 GMT SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”) announced today that GBT Tokenize Corp (“GBT/Tokenize”) engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm device. For more than 20 years, M2 has been providing a full range of regulatory, quality and clin...

Source: apnews.com
Investorideas.com Newswire - AI Eye Podcast 515: GBT Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina - Vimarsana News

Investorideas.com Newswire - AI Eye Podcast 515: GBT Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina

AI Eye Podcast 515: GBT Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina   Point Roberts, WA and Vancouver, BC - January 28, 2021 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence - featuring technology company GBT Technologies Inc. (OTCPINK:GTCH). Listen to today's podcast: SHARE PODCAST: Stocks discussed: (OTCPINK:GTCH)...